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).a b s t r a c t
DNA methylation represents an important link between structural genetic variation and complex phe-
notypes. The study of genome-wide CpG methylation and its relation to traits relevant to psychiatry has
become increasingly important. Here, we analyzed quality metrics of 394,043 CpG sites in two samples of
568 and 319 mentally healthy young adults. For 25% of all CpGs we observed medium to large common
epigenetic variation. These CpGs were overrepresented in open sea and shore regions, as well as in
intergenic regions. They also showed a strong enrichment of signiﬁcant hits in association analyses.
Furthermore, a signiﬁcant proportion of common DNA methylation is at least partially genetically driven
and thus may be observed similarly across tissues. These ﬁndings could be of particular relevance for
studies of complex neuropsychiatric traits, which often rely on proxy tissues.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Phenotypic differences between individuals are only partially
explained by genetic differences. Additional sources of variation,
including epigenetic regulation, are also centrally involved in trait
variability and disease etiology (Petronis, 2010). Among epigenetic
mechanisms, DNA methylation is being studied most extensively,
because the available technology allows for the investigation of
methylation patterns at both high resolution and throughput
(Bibikova et al., 2011). DNA methylation represents an important
connection between structural genetic variation and complex
phenotypes (Tan et al., 2015), a link that can be investigated by
epigenome-wide association studies (EWAS) (Jones, 2012; Rakyan
et al., 2011). However, EWAS are challenged by the highn of Molecular Neuroscience,
ik).
r Ltd. This is an open access articlecomplexity of the methylation signal, which displays variability
related to such factors as the speciﬁcs of the population being
studied, cell type, as well as temporal dynamics Davies et al., 2012;
Horvath et al., 2012; Lokk et al., 2014; Pidsley et al., 2014.
Furthermore, such signals consist of varying amounts of measure-
ment error and systematic variance of no interest (e.g. technical
artifacts).
Common epigenetic variation can be broadly deﬁned as the
signal's variability based on biologically or environmentally driven
factors but not based on technical confounders or random noise
(Altman, 2005; Flanagan, 2015). Given that the power of EWAS to
identify robust biomarkers is greater for common variants in
comparison to rare epimutations (Flanagan, 2015), an accurate
estimation of populations’ common epigenetic variation is of great
importance. Replication analysis can be used to estimate the
amount of a trait's naturally occurring variation (i.e. signals' vari-
ance exceeding the technical variance and random noise (Altman,
2005)) in a given population. Importantly, within the scope ofunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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done on different levels. Typically, analysis of technical replicates
for CpG methylation data has been done on a methylome-wide
level, by comparing the signal of all CpGs, e.g. by correlating two
technical replicates of one DNA sample across measured CpGs
(Tylee et al., 2013). Such analysis refers to comparing whole
methylation proﬁles. On this methylome-wide level, high repro-
ducibility within and between technologies has been shown
repeatedly (Bibikova et al., 2011; Sandoval et al., 2011), as expected
from the bimodal distribution of DNA methylation across the
methylome.
However, association studies such as EWAS are done on the
single-CpG level, where we often see an unimodal signal distribu-
tion (i.e. either high- or low- methylation sites). Therefore, we
aimed to estimate the amount of detectable common epigenetic
variation for each single CpG by evaluating the technical reliability
on the single-CpG level, i.e. by correlating two repeated measure-
ments of a single CpG site across samples. We performed a
comprehensive reliability analysis of the single-CpG DNA methyl-
ation signal from the Illumina Inﬁnium Human Methylation 450 K
array (450 K array), in a large sample of healthy young adults. We
used this reliability analysis to derive a lower bound estimate of the
common epigenetic variation, given its presumed strong associa-
tionwith complex phenotypes. Finallywe tested and replicated this
assumption by conducting a series of association studies with CpG
methylation in two independent samples.
2. Materials and methods
2.1. Subjects
The subjects included in this study (main sample N¼ 568; mean
age 23.8 y, 18.3e36.8 y; 59% females; independent replication
sample N¼ 319; mean age 24.1 y, 18.3e36.5 y; 70% females; the age
information refers to the time-point of the blood sampling, see
below) represent subsets of two ongoing studies, which were
previously described (Heck et al., 2014; Spalek et al., 2015). The
purpose of both studies is to identify biological correlates of
cognitive performance by using genetics, electroencephalography
and imaging techniques in healthy young adults from the general
population. Saliva samples were collected at the time-point of the
main investigation. Subjects were re-invited for an additional saliva
and blood sampling, which took place on average 360 days (min
1 day; max 1384 days; median 341 days) after the main investi-
gation. Samples were collected between midday and evening
(mean time ¼ 2:30 p.m., range 1:00 p.m. e 8:00 p.m.). Hemato-
logical analysis, including blood cell counts, was performed with
Sysmex pocH-100i™ Automated Hematology Analyzer (Sysmex Co,
Kobe, Japan). Subjects were of good general health, free of any self-
reported neurological or psychiatric illness and did not take any
medication (apart from oral contraception) at both time points. The
investigation was carried out in accordance with the latest version
of the Declaration of Helsinki. The ethics committee of the Cantons
of Basel-Stadt and Basel-Landschaft approved the studies. All par-
ticipants received general information about the study and gave
written informed consent.
2.2. Affymetrix SNP 6.0 based genotyping and imputation
DNA isolated from saliva was investigated with Affymetrix SNP
6.0 array as described in the Genome-Wide Human SNP Nsp/Sty 6.0
User Guide (Affymetrix, Santa Clara, CA USA; see Supplementary
Material). The mean call-rate per subject was 98.5% (90.1%e
99.7%). N ¼ 35 subjects out of the main sample were identiﬁed as
outliers and excluded from the association analyses (seeSupplementary Material). After basic SNP-QC (in both samples
MAF > 0.02; HWE > 0.001; missing rate per SNP < 5%)
N ¼ 659,944 SNPs entered the association analyses. Additionally
autosome-wide genotype imputation was performed (see
Supplementary Material).
2.3. HumanMethylation Inﬁnium 450 K BeadChip based
methylation analyses
Array processing (see Supplementary Fig. 1A): DNA isolated
from peripheral blood was investigated with the 450 K array
(Illumina, Inc., San Diego, CA, U.S.A; see Supplementary Material).
The N ¼ 568 subjects of the main sample were processed in two
batches (2 plates and 4 plates, respectively). For the independent
replication sample, N¼ 319 subjects were processed within a single
batch (4 plates). Within a batch samples were processed with a
randomized plate assignment and with a single bisulﬁte
conversion.
For N ¼ 145 subjects of the main sample a technical replication
was performed and processed on a 450 K array in parallel with the
two batches of the main sample (2 plates, 1 additional plate per
batch; technical replicates). Of note, the technical replicates of the
identical DNAwere not processed within the same time-point, and
hence were bisulﬁte-converted independently (see below). The
technical replication measurements were performed starting from
the identical DNA material as in the main sample (single DNA
isolation), with randomized assignment.
Data preparation on batch-level (see Supplementary Fig. 1B):
Preprocessing was done separately for each batch and also sepa-
rately for the technical replicates (two batches for themain sample;
two batches for the technical replicates; one batch for the inde-
pendent replication sample). Data were extracted and analyzed
from the generated idat ﬁles using the R package RnBeads version
0.99.9 (Assenov et al., 2014). CpG annotation was based on the
manufacturer’s annotation ﬁle (Human-
Methylation450_15017482_v.1.2). During preprocessing, the back-
ground was subtracted using the “noob” method in the methylumi
package (Davis et al., 2014), and the signal was further normalized
using the SWAN algorithm (Maksimovic et al., 2012). The following
probe categories were excluded from the ﬁnal data sets, based on
the annotation provided within the RnBeads package: non-CpG
context probes (due to underrepresentation on the 450 K array,
0.6%, (Bibikova et al., 2011), functional differences when compared
to CpG context as well as very low abundance of non-CpG
methylation in somatic tissues (Ziller et al., 2011); N ¼ 3091),
probes with a SNPmapping directly to the target CpG site, as well as
probes with three andmore SNPsmapping within the 50mer probe
(see Supplementary Fig. 2; MAF threshold was set to 0.01;
N ¼ 18,998 CpGs), gonosomal probes (N ¼ 11,473 CpGs), non-
speciﬁc probes. Using the Greedycut algorithm, we iteratively
removed the probes and data sets of the highest impurity (rows and
columns in the detection p-value table that contain the largest
fraction of unreliable measurements; p < 0.05 (Assenov et al.,
2014)).
Data preparation on sample-level (see Supplementary Fig. 1C):
Postprocessing was further done for each sample separately,
combining the b-values of the preprocessed data of all batches per
sample (see Supplementary Fig. 3A,C, as well as Supplementary
Figs. 4 and 5 for diagnostic plots of the data). The b-values were
further processed step-by-step in order to correct for further
inﬂuential and putative confounding factors: 1) using logit-
transformation (M-value, (Du et al., 2010), done with the R-pack-
age car (Fox and Weisberg, 2011)); 2) z-transformation per plate
(correcting for plate and batch effects); 3) regressing out the ﬁrst 8
(main sample and technical replicates) or 7 (independent
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done with the R-package pcaMethods (Stacklies et al., 2007); see
Supplementary Fig. 3B,D, as well as Supplementary Figs. 6 and 7
for diagnostic plots of the data after applying steps 1e3 of post-
processing). The PCA was based on CpGs with no missing values
(>95% of the included CpGs). The PCA-based approach corrected
for technical biases as well as for part of the variability induced by
blood cell composition (see Supplementary Tables 1 and 2,
Supplementary Figs. 9 and 10); 4) regressing out the effects of sex
and age; 5) regressing out the effects of variants in the 50mer
probe sequence, if the total variance explained by these variants
exceeded 0.1% (see Supplementary Material and Supplementary
Fig. 2).
The accepted missing rate per CpG was set to <1%. We further
excluded cross-hybridizing probes and polymorphic CpG sites
(Chen et al., 2013; Price et al., 2013) (Nmax ¼ 63,974). Only CpGs
surviving all ﬁltering steps in all samples were used for the
downstream analyses (N ¼ 394,043).
Cell-count estimates of cell types (CD 8 T helper cells, CD 4 T
helper cells, natural killer cells, B-cell, Monocytes, Granulocytes)
were donewith theminﬁ-package (Aryee et al., 2014) in R, based on
the algorithm provided by (Houseman et al., 2012), adapted for the
Illumina 450 K array (Jaffe and Irizarry, 2014).
To validate the applied batch and plate correction, we also used
ComBat (Johnson et al., 2007; Leek et al., 2012) instead of z-trans-
formation per plate, which lead to a nearly identical signal per CpG
(rmean ¼ 0.999). Optionally, we applied SQN (stratiﬁed quantile
normalization, with and without outlier exclusion; 5 samples were
identiﬁed as outlier) (Touleimat and Tost, 2012) as an alternative
data processing method (see Supplementary Fig. 8). When
compared with SWAN normalization, the two processing methods
produced on average a similar signal per CpG (rmean ¼ 0.75).
2.4. Technical replication analyses
All analyses of technical replicates were based on the N ¼ 145
individuals from the main sample for which technical replicates
were available. Pearson correlation coefﬁcients (r) were used for all
correlation analyses. The dataset used was analysis-dependent (see
below).
On the methylome-wide level, we calculated r between
methylation proﬁles for all CpGs based on the b-values of the main
sample and its technical replicates (see Supplementary Fig. 1D):
either for the identical DNA (within-subject comparison, N¼ 145 in
total) or for DNA of different subjects (between-subject compari-
sons; N ¼ 144 comparisons for each subject of the main sample
with all other subjects from the main sample and N ¼ 144 com-
parisons for each subject of the main sample with all non-identical
technical replicates).
On single-CpG level we calculated r separately for each CpG (see
Supplementary Fig. 1E), which resulted in N ¼ 394,043 correlation
coefﬁcients. This analysis was done after applying the logit trans-
formation (M-values), the correction for plate effects and the PCA
correction to the datasets. To further evaluate the distribution of
these r-values, we applied a Gaussian ﬁt allowing up to 5 over-
lapping Gaussian distributions by using the optimx function in R
(settings: method L-BFGS-B, ndeps 0.0001, maxit 40,000). When
allowing more than 5 Gaussian distributions, the contribution of
the additional sub-distribution reached 0% (see Supplementary
Fig. 11). The minimum and maximum values were restricted
to1m 1, 0 sd 1 and 0 p 1. The starting values were as
follows: m ¼ c(0, 0.5, 0.6, 0.7, 0.8); sd ¼ 0.12; p ¼ c(0.6, 0.1, 0.1, 0.1,
0.1).
To obtain a random r-distribution for a sample size of N ¼ 145
subjects, we repeatedly (N ¼ 400,000 times) generated twostandard normal random variables (length of 145 each) and
calculated r between these two variables.
2.5. Association analyses
The SNP-association studies were performed on a genome-wide
scale for each CpG separately assuming an additive genetic model
and applying an epi-genome-wide Bonferroni correction (a ¼ 5%,
correcting for 659,944  394,043 tests, resulting in
pbonf < 1.9  1013). We used M-values that were additionally cor-
rected for plate and batch effects, 7e8 axes of a PCA, sex and age as
well as effects of variants in the 50mer probe sequence (see
Supplementary methods). For the cis-analyses (deﬁned
as ± 3.5 Mbp), we used a less stringent signiﬁcance threshold
pcis < 1.7  105 (a ¼ 5%, correcting for at least 3000 independent
tests per CpG).
To evaluate the associations with sex and age we used the PCA
corrected dataset (M-values that were additionally corrected for
plate and batch effects as well as 7e8 axes of a PCA). A linear model
was calculated for each CpG, including sex and age as independent
variables (per independent variable a ¼ 5%, 394,043 independent
tests, p < 1.3  107). Because sex and age were profoundly asso-
ciated with cell-count estimates (main sample R2sex ¼ 16.32%,
p < 2.2  1016, R2age ¼ 6.21%, p ¼ 7.28  106; independent
replication sample R2sex ¼ 26.01%, p < 2.2  1016, R2age ¼ 7.76%,
p ¼ 2.94  104), we additionally used cell-count estimates as
covariates in the model. We estimated standardized betas for sex
and age by z-transforming the input variables.
For the associationwith smoking, we used the data that was also
corrected for sex and age (after the PCA correction) and calculated r
between single CpGs and smoking frequency (a ¼ 5%, 394,043 in-
dependent tests, p < 1.3  107). Smoking frequency was assessed
on a 4-point Likert scale (0 ¼ never, 1 ¼ occasionally, 2 ¼ 1e5
cigarettes/day, 3 ¼ 6e20 cigarettes/day, 4 ¼ 20 or more cigarettes/
day; see Supplementary Fig. 12) during the main investigation.
There was no signiﬁcant association between cell-count estimates
and smoking (main sample R2smoking ¼ 1.2%, p ¼ 0.38; independent
replication sample R2smoking ¼ 0.45%, p ¼ 0.97).
We compared the association results of sex, age and smoking
with the following external datasets: sex (Xu et al., 2014), age
(Horvath, 2013) and smoking (Guida et al., 2015; Shenker et al.,
2013).
To assess the effects of batch and plate, we used the uncorrected
b-values as dependent variable and calculated one linear model per
CpG with one combined factor for batch and plate, since batch and
plate were largely confounded (see Supplementary Fig. 1). We
report the overall R2 of this model as effect-size estimate.
2.6. Genomic representation analyses
We used the manufacturer’s annotation ﬁle (Human-
Methylation450_15017482_v.1.2) to classify CpGs based on their
CpG density (Island, N_Shelf, N_Shore, Open_Sea, S_Shore, S_Shelf)
as well as based on functional regions (1st Exon, 30UTR, 50UTR,
Body, Intergenic, TSS1500, TSS200). We used the genomic hg19
database (genome-mysql.cse.ucsc.edu) to retrieve data about
DNase I hypersensitivity cluster (table wgEncodeR-
egDnaseClusteredV3) and data about H3K27ac histone modiﬁca-
tion marks (data derived from wgEncodeBroadHistone-XXX-cell-
type-XXX-H3k27acStdSig.bigWig for the cell-types Gm12878,
H1hesc, Hsmm, Huvec, K562, Nhek, Nhlf; data has been log-
transformed). We compared CpGs showing high and low natural
occurring variation with respect to these genomic representations
either by using the Chi2-test to compare frequencies or the
Kolmogorov-Smirnov test to compare distributions.
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If not mentioned differently, analyses were conducted in R
(version: 2.15.1 and higher, R Development Core Team, 2012) or
PLINK (Purcell et al., 2007).
3. Results
3.1. Methylome-wide reliability analyses
These analyses were done with the untransformed b-values.
Based on the b-distribution on methylome-wide level (Fig. 1A), we
ﬁrst compared DNA methylation proﬁles of the identical DNA
(within subjects comparison). Here, we observed high signal
reproducibility of technical replicates (see Table 1; see Fig. 1B for
one example). This was in agreement with previous reports
(Bibikova et al., 2011; Sandoval et al., 2011). Next, we compared
DNA methylation proﬁles between subjects (see Fig. 1C for one
example). The estimated signal similarity between DNA of different
subjects also suggested very high signal consistency on
methylome-wide level (see Table 1). Subsequently, for each dataset
of the main sample we tested, which of the remaining datasets of
the main sample (including technical replicates) showed the
highest similarity on methylome-wide level (top-hit). For 89% of
these comparisons, the highest similarity was obtained with its
technical replicate, i.e. identical DNA that has been processed
independently.Fig. 1. Methylation signal distributions and replication analyses. (A) b-distribution on m
methylome data sets, from the main sample and from its technical replicate, are shown. b-v
two different subjects. (D) b-distribution shown for two distinct CpGs, separately for the ma
b-values of two distinct CpGs plotted against each other (N ¼ 145 samples with technical r3.2. Single CpG level reliability analyses e estimation of natural
occurring variation
With the technical replication analysis on the single-CpG level
(Fig. 1DeF) we further aimed to detect CpGs that comprise a sig-
niﬁcant amount of common epigenetic variation, within those
samples with a technical replicate. We therefore focused on sepa-
rating the technical variation or random noise from the overall
detected signal. For this analysis we used data after logit-
transformation (M-values) that was additionally corrected for
plate and batch effects as well as the ﬁrst 8 axes of a PCA, i.e. that is
corrected for additional confounders (see Supplementary Table 1).
Taking into account all N ¼ 394,043 CpGs, the average r per
single-CpG was 0.191 (rmin ¼ 0.361, rmax ¼ 0.988). Fig. 2A shows
the distribution of r-values across all CpGs. Inﬁnium type II probes
in comparison to type I probes showed on average higher r-values
(type I rmean ¼ 0.17; type II rmean ¼ 0.20; Supplementary Fig. 13).
After applying an FDR-correction for multiple testing, 134,385 CpGs
showed a signiﬁcant positive correlation (a ¼ 5%, r > 0.198). To
further examine this distribution, we applied a Gaussian mixture
model allowing up to ﬁve Gaussian distributions (Fig. 2A), which
indicated that for approximately 53% of the CpGs in our sample the
observed signal variability was likely based on random or technical
variance (red sub-distribution Fig. 2A, mean ¼ 0.03, sd ¼ 0.09;
alternative Gaussian mixture models suggest similar conclusion,
see Supplementary Fig. 11). The majority of these CpGs' r-values
were below 0.3. We compared this ﬁtted distribution with aethylome level, shown for the DNA of two different subjects. For the ﬁrst subject, both
alues on methylome level plotted against each other from (B) the same subject and (C)
in sample and its technical replicate (N ¼ 145 pairs with technical replicates). (E and F)
eplicates). r: Pearson correlation coefﬁcient.
Table 1
Methylome-wide reliability analyses. For the analytical schema see also Supplementary Fig. 1D.
Comparison between: Mean r Min r Max r % of top-hit
Technical replicates (identical DNA) 0.997 0.990 0.999 89
Different DNA within the main sample 0.995 0.988 0.997 11
Different DNA between the main sample and non-identical technical replicates 0.994 0.985 0.997 0
r: Pearson correlation coefﬁcient.
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data sets (Fig. 2B; mean ¼ 0, sd ¼ 0.08). The ﬁtted distribution
showed a slight shift to the right and was slightly wider than the
generated random distribution (mean ¼ 0.03 in comparison to 0;
sd ¼ 0.09 in comparison to 0.08; Kolmogorov-Smirnov test
D¼ 0.14, p < 2.2 1016), indicating that within these CpGs, there is
still some non-random variation. Based on the visual inspection of
the plots, and speciﬁcally the boundaries of the red sub-
distribution, we deﬁned an r-threshold of 0.3 to separate CpGs
that show a considerable part of common epigenetic variation,
from CpGs showing very low amount of common epigenetic vari-
ation. When applying this threshold, type II probes in comparison
to type I probes showed a signiﬁcantly higher proportion of reliable
CpGs (20.8% of all type I probes versus 27.1% of all type II probes;
c2 ¼ 1628.56, df ¼ 1, p < 2.2  1016).
For the CpGs with r 0.3 (reliable CpGs, N¼ 99,839) we assume
that they robustly capture the underlying common epigenetic
variation. These CpGs exhibited a higher inter-individual variability
in comparison to CpGs with an r < 0.3 and had less extreme b-
values (Figs. 3 and 1D-F; Supplementary Figs. 14 and 15). On the
other hand, the signal coming from the subset of CpGs with an
r < 0.3 most likely comprised a mixture of two different categories:
random signals or signals with very low natural epigenetic varia-
tion (~2/3 of all CpGs with r < 0.3; red sub-distribution in Fig. 2A)
and signals with amedium to lownatural epigenetic variation (~1/3
of all CpGs with r < 0.3; light-green sub-distribution in Fig. 2A).
Differences in data post-processing could potentially bias the
technical replication analysis. Therefore, we performed thereliability analysis on the CpG level upon different post-processing
steps (Supplementary Fig. 16). Correcting for the technical in-
ﬂuences of plate and batch improved the reproducibility on the
single-CpG level. To additionally evaluate the impact of the tech-
nical factors batch and plate on the single-CpG signal distribution,
we compared the signals mean and standard deviation with the
estimated variance explained (R2) by these technical factors: CpGs
with lower variability and more-extreme b-values showed more-
prominent batch and plate-effects than CpGs with higher vari-
ability and less-extreme b-values (Supplementary Fig. 17). A
possible explanation is that more-extreme and less-variable CpGs
are more-often monomorphic, and that the detected variability is
primary due to technical artifacts. The PCA-correction applied
could not entirely correct for cell-type composition (see
Supplementary Figs. 9 and 10). As a consequence, there was still
enrichment for association signals with cell-count estimates after
PCA-correction, which was more pronounced for reliable CpGs
especially in our samples (Supplementary Fig. 18).
3.3. Association analyses
Having detected CpGs that are likely to show considerable
amounts of naturally occurring variation, we next assessed the
phenotypic relevance of such variation by means of signiﬁcant hits
in association studies using CpG methylation as dependent vari-
able. Previously it has been demonstrated that DNA methylation
can be inﬂuenced by genetic variation (Schalkwyk et al., 2010;
Shoemaker et al., 2010), sex and age (Horvath, 2013; Xu et al.,
0.0 0.2 0.4 0.6 0.8 1.0
0
1
2
3
4
β mean
D
en
si
ty
A
r ≥ 0.3
r < 0.3
0.00 0.05 0.10 0.15 0.20 0.25 0.30
0
10
20
30
40
50
β sd
D
en
si
ty
B
r ≥ 0.3
r < 0.3
Fig. 3. Density distributions of the beta's mean and sd, depending on the estimated common variation of the CpGs. CpGs for which common variation could be robustly
detected were less likely to show extreme b-values (A) and showed a wider distribution (B). sd: standard deviation. r: Pearson correlation coefﬁcient.
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Shenker et al., 2013). Hence, we calculated EWAS for genetic vari-
ants, sex, age and smoking in the main sample (N ¼ 533, after
exclusion of genetic outliers) as well as in the independent repli-
cation sample (N ¼ 319). For these analyses we used M-values that
were at least corrected for plate effects and for the ﬁrst 7e8 axes of
a PCA (for more speciﬁc information see methods).
3.3.1. meQTL analysis
To investigate the effect of SNPs on single-CpG methylation
levels (meQTL), we ﬁrst performed genome-wide association ana-
lyses on all 394,043 CpGs. Based on the main sample, this analysis
identiﬁed for 8.2% of all CpGs at least one signiﬁcant meQTL (see
Table 2). As expected (Schalkwyk et al., 2010; Shoemaker et al.,
2010), most of the top meQTLs were in cis of the investigated CpG
(±3.5 Mbp, 95.5%).
Hence, we restricted the main analysis to a ±3.5 Mbp window
surrounding the investigated CpG (cis analysis) and applied a less
stringent p-value threshold (p < 1.7  105). Based on the main
sample, we identiﬁed for 20% of all CpGs at least one signiﬁcant
meQTL in cis (Table 3). The results of the two samples showed high
concordance rates for the meQTL association analysis
(Supplementary Fig. 19A). CpGs that were more likely to capture
common epigenetic variation showed a pronounced enrichment of
signiﬁcant association signals in both of the tested samples (Fig. 4A;
Table 4).
Finally, we estimated the impact of the sequentially applied
post-processing steps on the detection of meQTLs by repeating the
same analysis for all post-processing steps. The PCA correction lead
to an increase in power to detect meQTLs (Supplementary Table 3)
whereas the correction of variants in the 50mer probe sequence
sufﬁciently reduced biases of these variants in the detection of
meQTLs (about 10% more hits without 50mer probe correction;
Supplementary Table 4).Table 2
Genome-wide meQTL-analyses.
Analysis N CpG-SNP pairs
Main sample 304,706
Independent Replication sample 170,940
DNA methylation data was corrected for variants in the 50mer probe sequence; signiﬁca3.3.2. Association with sex, age and smoking
The phenotypic analyses revealed largely overlapping signiﬁ-
cant associations in both samples (Supplementary Fig. 19;
Supplementary Table 5) with sex (N ¼ 5106 in total: main sample
N ¼ 4958 CpGs, independent replication sample N ¼ 1551 CpGs,
overlap between samples N ¼ 1403; N ¼ 892 have been reported
previously (Xu et al., 2014)), age (N ¼ 409 in total: main sample
N ¼ 352 CpGs, independent replication sample N ¼ 171 CpGs,
overlap between samples N ¼ 114; N ¼ 13 have been reported
previously (Horvath, 2013)) and smoking (N ¼ 19 in total: main
sample N ¼ 14 CpGs, independent replication sample N ¼ 16 CpGs,
overlap between samples N ¼ 11; N ¼ 18 have been reported pre-
viously (Guida et al., 2015; Shenker et al., 2013)). Again, CpGs that
were more likely to capture common epigenetic variation were
more likely to show signiﬁcant association results in both samples
(Fig. 4BeD and Table 4). Of note, only autosomal CpGswere used for
the association analysis. For all phenotypes the effect-size esti-
mates from our study were in concordance (jrj > 0.4;
Supplementary Figs. 20 and 21) with previously reported effect-
size estimates (Guida et al., 2015; Horvath, 2013; Shenker et al.,
2013; Xu et al., 2014).
3.4. Genomic representation of CpGs with respect to the common
epigenetic variation
CpGs were classiﬁed with respect to the genomic location in the
following categories: open sea, shore, shelf and island (Bibikova
et al., 2011). CpGs comprising higher common epigenetic varia-
tion were overrepresented in open sea and shores, and underrep-
resented in CpG islands (c2 ¼ 6707.08, df ¼ 5, p < 2.2  1016; see
Table 5). Accordingly, these CpGs were also overrepresented in
intergenic regions (c2 ¼ 7324.52, df ¼ 6, p < 2.2  1016; see
Table 6), and showed less enrichment for DNase I hypersensitivity
(D ¼ 0.14, p < 2.2  1016) and for the histone modiﬁcation markN unique CpGs % of CpGs N unique SNPs
32,216 8.2 130,208
22,308 5.7 85,301
nce threshold was set to p < 1.9  1013.
Table 3
meQTL-analyses in CIS (±3.5 Mb window).
Analysis N CpG SNP pairs N unique CpGs % of CpGs N unique SNPs
Main sample 956,378 78,725 20.0 276,739
Independent replication sample 641,288 65,388 16.6 221,528
DNAmethylation data was corrected for variants in the 50mer probe sequence. N ¼ 49,626 of the unique CpGs showed a signiﬁcant SNP-hit in cis in both studies; signiﬁcance
threshold was set to pcis < 1.7  105.
Fig. 4. QQ-plot of the association analyses. CpGs were classiﬁed in 3 groups, depending on the technical replication analyses and estimated common variation (orange r  0.3;
grey 0 > r < 0.3; black r < 0.3). For each group separately, the results of a QQ-plot for the main sample (left) and the independent replication sample (right) are shown. (A) depicts
the results of the meQTL analyses in cis (p-value of the tophit SNP), (B) of the association with sex, (C) of the association with age and (D) of the association with smoking. r: Pearson
correlation coefﬁcient. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 4
Number of hits in the association analysis, depending on the technical reliability r per CpG.
Study Analysis r  0 (N ¼ 84,972) 0 < r < 0.3 (N ¼ 209,232) r  0.3 (N ¼ 990839)
Main sample meQTL in cis 4.93% (N ¼ 4,192) 11.99% (N ¼ 25,083) 49.53% (N ¼ 49,450)
Ind. repl. sample meQTL in cis 4.57% (N ¼ 3,880) 9.53% (N ¼ 19,947) 41.63% (N ¼ 41,561)
Main sample Sex 0.02% (N ¼ 19) 0.23% (N ¼ 487) 4.46% (N ¼ 4,452)
Ind. repl. sample Sex 0.01% (N ¼ 5) 0.06% (N ¼ 119) 1.43% (N ¼ 1,427)
Main sample Age 0% (N ¼ 0) 0.02% (N ¼ 37) 0.32% (N ¼ 315)
Ind. repl. sample Age 0% (N ¼ 0) 0.01% (N ¼ 22) 0.15% (N ¼ 149)
Main sample Smoking 0% (N ¼ 0) 0% (N ¼ 1) 0.01% (N ¼ 13)
Ind. repl. sample Smoking 0% (N ¼ 0) 0% (N ¼ 1) 0.02% (N ¼ 15)
Ind. repl. sample: independent replication sample.
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Fig. 22).
4. Discussion
In the present study we performed comprehensive reliability
analysis of the 450 K array in a large sample of healthy young
adults. Based on the reliability analysis on the single-CpG level we
estimated a medium to large common epigenetic variation (r > 0.3;r2 > 9%) for 25% of the examined CpGs. These CpGs were less often
hyper- and hypomethylated and showed a higher variability in the
investigated population. Additionally, these CpGs were over-
represented in low CpG density genomic regions like open sea
and shores, as well as in intergenic regions, which was in agree-
ment with a previous report (Gibbs et al., 2010). Accordingly, these
CpGswere depleted in DNase I hypersensitivity and H3ak27ac sites.
Furthermore, CpGs with an estimated higher epigenetic variability
showed an enrichment of signiﬁcant association signals for meQTLs
Table 5
Percentage of CpGs within different genomic regions, in relation to CpG density.
% r < 0.3 r  0.3
Island 36.15 23.57
N_Shelf 4.86 4.66
N_Shore 11.95 17.08
Open_Sea 33.41 37.00
S_Shore 9.28 13.62
S_Shelf 4.35 4.06
N_Shore and S_Shore are 2 kb regions ﬂanking CpG islands, upstream and down-
stream respectively; N_Shelf and S_Shelf are 2 kb regions ﬂanking CpG island
shores, upstream and downstream respectively. The remaining CpG were assigned
to Open _Sea.
Table 6
Percentage of CpGs within different genomic regions, in relation to the transcripts
“functional regions”.
% r < 0.3 r  0.3
1st Exon 5.38 3.54
30UTR 3.90 2.96
50UTR 9.70 7.54
Body 33.97 33.17
Intergenic 19.61 30.78
TSS1500 14.50 14.74
TSS200 12.94 7.26
TSS200 is the region from Transcription start site (TSS) to 200 nt upstream of TSS;
TSS1500 covers 200 to 1500 nt upstream of TSS.
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variability across a population (Flanagan, 2015). Importantly, we
could robustly conﬁrm the association ﬁndings in an independent
replication sample, and could also replicate previously reported
ﬁndings for all phenotypes (Guida et al., 2015; Horvath, 2013;
Shenker et al., 2013; Xu and Taylor, 2014).
Technical replication analysis on a single-CpG level can help to
identify CpGs that show common epigenetic variation in the
investigated population. However, it is important to stress that we
cannot draw ﬁnal conclusions with regard to CpGs that showed no
or very low common epigenetic variation. Variability of such CpGs
may change as a function of sample size, tissue selection, samples’
environmental background, genetic background, or disease status.
By analyzing a large sample of healthy young adults in one tissue
(i.e. blood) we most likely estimated a lower-bound variability for
single-CpGs. Yet, these results may serve as a baseline reference for
the naturally occurring epigenetic variation of speciﬁc CpGs, in a
population of a similar origin and structure.
The results of the meQTL analyses are in line with previous
studies that examined genotype-epitype associations in cell lines
(Bell et al., 2011; Heyn et al., 2013), peripheral blood (McClay et al.,
2015) and brain samples (Gibbs et al., 2010; Zhang et al., 2010). Of
note, by focusing on the CpGs that show common epigenetic vari-
ation we could detect a profound enrichment of meQTLs, when
compared to previous studies. Therefore, the subset of reliably
measured CpGs could be valuable for studies of complex traits since
it additionally delineates the common epigenetic variation deter-
mined by the underlying genetic architecture. Given that cross-
tissue studies suggest a high level of meQTL conservation across
tissues (Gibbs et al., 2010; Smith et al., 2014), it is also likely that the
captured common epigenetic variation shows similar conservation
across tissues. This is important, especially in the context of studies
where obtaining material from the target tissue is not feasible or
results in low sample size. By focusing on meQTLs ﬁndings in proxy
tissues it may be possible to reﬂect changes in the remote target
tissues, e.g. brain.
Lack of reliability on a single-CpG level in our samplemay reﬂecta truly invariant signal (e.g. the CpG is highly methylated in all
subjects), for which the measured variability is only due to chance
or technical inﬂuences. However, failure to detect systematic vari-
ance can also be caused by the speciﬁcs of the microarray tech-
nology, including a ﬁxed and limited signal resolution (Bibikova
et al., 2011). Sequencing technologies can bypass this issue via
customized signal resolution, e.g. by optimizing sequencing depth
(Bock, 2012). Increasing sequencing depth, however, increases
costs, while still being faced with the challenges of signal reliability.
Taken together, our results indicate that for the 450 K array, a
relevant percentage (>25%) of single CpGs shows a medium to
strong common epigenetic variation in a homogenous sample of
healthy young adults. These ﬁndings could serve as a baseline-
determination of CpGs that show natural epigenetic variation in a
population of similar origin and structure. These CpGs also show a
strong enrichment of signiﬁcant hits in association analyses. The
strong genetic component for CpGs comprising common epigenetic
variation additionally suggests that a signiﬁcant proportion of
common DNA methylation variation may be shared across tissues.
These ﬁndings could be of special relevance for studies of complex
phenotypes, as in the case of neuropsychiatric disorders that often
rely on proxy tissue.
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